2017
DOI: 10.1016/j.neubiorev.2017.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward

Abstract: Schizophrenia is a severe mental illness that causes major functional impairment. Current pharmacologic treatments are inadequate, particularly for addressing negative and cognitive symptoms of the disorder. Oxytocin, a neuropeptide known to moderate social behaviors, has been investigated as a potential therapeutic for schizophrenia in recent years. Results have been decidedly mixed, leading to controversy regarding oxytocin's utility. In this review, we outline several considerations for interpreting the ext… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
71
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(72 citation statements)
references
References 271 publications
(377 reference statements)
1
71
0
Order By: Relevance
“…Further, there have been several treatment efforts targeting cognition that have been applied to substance abuse in dual diagnosis populations. Pharmacological treatments aimed at cognition and social cognition have been disappointing, 29,30 and so herein we focus on Computerized Cognitive Training (CCT) and Computerized Social-Cognitive Training (CSCT). An overview of the CCT and CSCT evaluation studies that we discuss is presented in Table 1.…”
Section: Interventions Targeting Cognitive and Social-cognitive Deficitsmentioning
confidence: 99%
“…Further, there have been several treatment efforts targeting cognition that have been applied to substance abuse in dual diagnosis populations. Pharmacological treatments aimed at cognition and social cognition have been disappointing, 29,30 and so herein we focus on Computerized Cognitive Training (CCT) and Computerized Social-Cognitive Training (CSCT). An overview of the CCT and CSCT evaluation studies that we discuss is presented in Table 1.…”
Section: Interventions Targeting Cognitive and Social-cognitive Deficitsmentioning
confidence: 99%
“…Currently, oxytocin is considered as a potential neuropeptide to improve social communication [123,124], the ability to understand other people's feeling [14], autism Neuroendocrinology 2018;107:91-104 DOI: 10.1159/000489263 [17], and schizophrenia [18] in humans. In addition, obesity prevention is expected in future through the use of oxytocin treatment.…”
Section: Clinical Implications Of Oxytocinmentioning
confidence: 99%
“…However, recent studies have discovered its new physiological functions, which include increased trust in humans [7,8], change of paternal and maternal behavior toward their children [9][10][11], increase in pair bonding [12,13], and an increased ability to understand other people's feelings or improvement of social communication [14][15][16]. In addition, there are many articles related to the role of oxytocin in psychiatric diseases [17][18][19][20].…”
Section: Introductionmentioning
confidence: 99%
“…43 Moreover, OT regulates the way in which individuals process emotional information 44 and, in turn, facilitates the identification of emotions 45 ; as such OT may be implicated in many mental health disorders. Altered OT concentrations or responses are evident in patients with postnatal depression, 46 schizophrenia, 47 autism spectrum disorder (ASD) 48 and attention-deficit hyperactivity disorder. 49 Given OT's pivotal role in adaptive social behaviour, studies have investigated the potential therapeutic role of OT administration in improving characteristic behavioural symptoms associated with these disorders.…”
Section: Psycholog Ic Al Effec Tsmentioning
confidence: 99%